APA (7th ed.) Citation

Rosa, L. I. D., Catania, M., Kola, K., Paolisi, M., Bianca, P., Manunta, P., . . . Alibrandi, M. T. S. (2025). Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes. Elsevier.

Chicago Style (17th ed.) Citation

Rosa, Liliana Italia De, Martina Catania, Kristiana Kola, Michele Paolisi, Pierpaolo Bianca, Paolo Manunta, Giuseppe Vezzoli, and Maria Teresa Sciarrone Alibrandi. Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes. Elsevier, 2025.

MLA (9th ed.) Citation

Rosa, Liliana Italia De, et al. Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes. Elsevier, 2025.

Warning: These citations may not always be 100% accurate.